comparemela.com

Latest Breaking News On - உறுதிப்படுத்தல் எண் - Page 1 : comparemela.com

Agenus to Provide Corporate Update and First Quarter 2021 Financial Report

Agenus to Provide Corporate Update and First Quarter 2021 Financial Report Conference Call on Thursday, May 6, 2021 at 8:30 a.m. ET LEXINGTON, Mass., April 22, 2021 (GLOBE NEWSWIRE) Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that it will release its first quarter 2021 financial results before the market opens on Thursday, May 6, 2021. Agenus executives will host a conference call and webcast at 8:30 a.m. ET the same day to discuss the results and to provide a corporate update. Conference Call Webcast A live webcast and replay of the conference call will be accessible from the Events & Presentations page of the Company’s website at https://investor.agenusbio.com/events-and-presentations and via https://edge.media-server.com/mmc/p/dbt4fxyo.

GPSC Agriculture Officer Prelims 2021: Admit card released, check steps to download here

GPSC Agriculture Officer Prelims 2021: Admit card released, check steps to download here GPSC Agriculture Officer Prelims 2021: Admit card released, check steps to download here GPSC Agriculture Officer Prelims 2021 admit card has been released at gpsc-ojas.gujarat.gov.in. advertisement GPSC Agricultute Officer Prelims 2021 admit card has been released. HIGHLIGHTS Candidates can download their admit card from gpsc-ojas.gujarat.gov.in GPSC Agriculture Officer Prelims 2021 has been scheduled to be held on April 11, 2021 GPSC Agriculture Officer Prelims 2021 admit card has been released by the Gujarat Public Service Commission GPSC. Candidates who have applied to appear for the Agriculture Officer Prelims Exam 2021, can download their admit card by using their ID and password from the official website of GPSC, i.e., gpsc-ojas.gujarat.gov.in.

H-1B registration process to begin on March 9, followed by lottery

H-1B registration process to begin on March 9, followed by lottery Top Searches H-1B registration process to begin on March 9, followed by lottery FacebookTwitterLinkedinEMail MUMBAI/BENGALURU: The United States Citizenship and Immigration Services (USCIS) has announced the dates to kick off the registration and application process for H-1B cap visas, by sponsoring employers. The initial registration period for the fiscal year 2022 (which ends on September 30, next year) will open on March 9 and run through March 25. This is the second year that the E-registration process will be adopted. Sponsoring employers will be required to fill out basic information, including details of the proposed employee (beneficiary) for whom the H-1B visa is being sought. A confirmation number will be given to each registration.

Poxel Announces Additional Positive Phase 2a Results, and Phase 2b Plan for PXL770, an Oral First-in-Class AMPK Activator, in NASH - Press Release

statistically significant vs. placebo or baseline (p 0.05) ^(p 0.08; 0.052) “There is a sizable overlap in the NASH patient population such that approximately 50% of NASH patients also have co-existing type 2 diabetes. PXL770 is one of the only therapies in development that has demonstrated the potential to treat NASH with specific use in patients with coexisting type 2 diabetes that are at higher risk for faster disease progression and for co-morbidities, including cardiovascular complications,” commented Pascale Fouqueray, MD, PhD, Executive Vice President, Clinical Development and Regulatory Affairs at Poxel. “AMPK activation has the potential to improve the underlying root causes of NASH, such as insulin resistance, the dysregulation of lipid and glucose metabolism and inflammation. We believe PXL770 has the potential to be a much-needed and differentiated therapeutic option for NASH and could be particularly important for the high-risk population with type 2 diabet

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.